Cassava vein mosaic virus promoters nucleic acid sequences and expression vectors
AssigneeThe Scripps Research Institute
InventorsBertrand Verdaguer, Alexandre de Kochko, Roger Beachy, Claude Fauquet
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Scripps Research Institute
InventorsBertrand Verdaguer, Alexandre de Kochko, Roger Beachy, Claude Fauquet
Estimating the term…
The invention relates to compositions and methods useful for the production of transgenic plants. In particular, the invention relates to cassava vein mosaic virus (CsVMV) promoter sequences sequences and expression cassettes containing CsVMV promoter sequences. The invention describes nucleic acid molecules, vectors and transgenic plants containing promoters derived from CsVMV promoter that are operatively linked to heterologous DNA sequences, and methods for producing transgenic plants containing these promoters.
1-9. (canceled)
A transgenic plant comprising a promoter nucleotide sequence that is capable of initiating transcription of an operably linked heterologous nucleic acid sequence in a plant cell wherein said promoter nucleotide sequence has at least 80% identity to 18 sequential nucleotides of the cassava vein mosaic virus (CsVMV) promoter shown in SEQ ID NO 3 (pA) and is operatively linked to said heterologous nucleic acid sequence.
11-15. (canceled)
A transgenic plant comprising a CsVMV promoter nucleotide sequence and a heterologous nucleotide sequence, wherein said CsVMV promoter nucleotide sequence and said heterologous nucleotide sequence are operatively linked, and wherein said CsVMV promoter nucleotide sequence initiates transcription of said heterologous nucleic acid sequence in a cell of said transgenic plant.
A transgenic plant comprising a CsVMV promoter nucleotide sequence, wherein said CsVMV promoter nucleotide sequence consists essentially of SEQ ID NO:3 or a fragment thereof having promoter activity.
A transgenic plant comprising a CsVMV promoter nucleotide sequence, wherein said CsVMV promoter nucleotide sequence does not include a naturally occurring CsVMV genomic sequence adjacent to said CsVMV promoter nucleotide sequence.
A transgenic plant comprising a recombinant CsVMV promoter nucleotide sequence.
Dependencies are inferred from the claim text.